DocTalks: Cell Engineering and Therapy

Engineering the body’s own cells into living medicines is a revolutionary new approach to advance patient care in many areas. From cancers and blood disorders to neurodegenerative conditions, autoimmune diseases, and organ transplant recovery, cell therapies are raising the possibility of long-term remission and even cures. There are now nearly 2,000 cell and gene therapy clinical trials underway globally. Our panel will explore how Columbia’s scientists are leading this effort, including by expanding the reach of CAR-T cell therapy, a powerful tool that has already transformed outcomes for certain cancers.

MODERATOR:
Siddhartha Mukherjee, MD, DPhil
2011 Pulitzer Prize Winner
Associate Professor of Medicine
Columbia University Vagelos College of Physicians and Surgeons

PANELISTS:
Ben Izar, MD, PhD
Vivian and Seymour Milstein Family Associate Professor of Medicine in the Division of Hematology and Oncology
Associate Professor of Systems Biology
Columbia University Vagelos College of Physicians and Surgeons

Claire S. Riley, MD
Karen L. K. Miller Associate Professor of Neurology
Director, Columbia University Multiple Sclerosis Center
Columbia University Vagelos College of Physicians and Surgeons

Michel Sadelain, MD, PhD
Herbert and Florence Irving Professor of Medicine
Director, Columbia Initiative in Cell Engineering and Therapy
Director, Cell Therapy Program in the Herbert Irving Comprehensive Cancer Center
Columbia University Vagelos College of Physicians and Surgeons

Catherine Spina, MD, PhD
Associate Professor of Radiation Oncology
Columbia University Vagelos College of Physicians and Surgeons